Mary Alice Hall, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 9140 Highway 51 N # South, Southaven, MS 38671 Phone: 662-280-8222 Fax: 662-280-5541 |
Mrs. Christa Casey Dunlop, Registered Nurse - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 8626 Airways Blvd, Southaven, MS 38671 Phone: 662-772-5937 Fax: 662-772-5940 |
Laquitta Hughes, FNP-C Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5375 Savannah Pkwy, Southaven, MS 38672 Phone: 601-941-2410 |
Tiffany Jackson, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5875 Landau Dr, Southaven, MS 38671 Phone: 870-821-1234 |
Stevie Lamar Dunn, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3146 Central Pkwy, Southaven, MS 38672 Phone: 662-212-3555 |
Mr. Henon Lee Mcdonald Jr., RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3316 Devonshire Cv N, Southaven, MS 38672 Phone: 901-292-3047 |
Ashley Nicole Walker, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 7601 Southcrest Pkwy, Southaven, MS 38671 Phone: 662-772-4000 |
Tamara Pittman-johnson, Registered Nurse - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1019 Worthington Dr, Southaven, MS 38671 Phone: 901-494-5175 |
Mrs. Whitney Barrier Brock, NP-C Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 401 Southcrest Cir Ste 212, Southaven, MS 38671 Phone: 662-245-5270 |
Terri Lynn Wright, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 7737 Fernwood Cv, Southaven, MS 38671 Phone: 901-592-7092 |
Kameshia Harris, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3868 Washington Woods Rd, Southaven, MS 38672 Phone: 662-312-8801 |
Mrs. Chelsea Colby Obiedzinski, FNP-C Registered Nurse Medicare: May Accept Medicare Assignments Practice Location: 346 Stateline Rd W, Southaven, MS 38671 Phone: 662-510-5353 |
Cashandra L Hooper, Registered Nurse - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 340 Stateline Rd W, Southaven, MS 38671 Phone: 662-579-3955 |
Mary Manning Booker, PMHNP-BC Registered Nurse - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2686 Pinnacle Dr, Southaven, MS 38672 Phone: 662-306-3081 |
John Walker, CRNA Registered Nurse - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 7601 Southcrest Pkwy, Southaven, MS 38671 Phone: 662-772-4000 |
Teresa D Kendrick, NP Registered Nurse - Psych/Mental Health, Adult Medicare: Accepting Medicare Assignments Practice Location: 5699 Getwell Rd, Suite 5, Building F, Southaven, MS 38672 Phone: 662-649-6502 |
Jerry Randall Stark, RN Registered Nurse - Emergency Medicare: Not Enrolled in Medicare Practice Location: 848 Valley Springs Dr, Southaven, MS 38671 Phone: 901-337-7778 |
Olivia Jane Ball, PMHNP-BC Registered Nurse Medicare: Medicare Enrolled Practice Location: 340 Stateline Rd W, Southaven, MS 38671 Phone: 662-579-3955 |
Tonya C Benson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 340 Stateline Rd W, Southaven, MS 38671 Phone: 662-579-3955 |
Neperterri Latrice Taylor, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 340 Stateline Rd W, Southaven, MS 38671 Phone: 662-510-5387 |
News Archive
Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Novelos entered into a definitive agreement with Purdue Pharma L.P., an existing investor, to sell 13,636,364 shares of its common stock and warrants, expiring on December 31, 2015, to purchase an aggregate of approximately 4,772,728 shares of common stock at an exercise price of $0.66 per share, for gross proceeds of $9 million.
UK scientists hope that lymphoma patients could benefit from a new drug that triggers the cancer-fighting properties of the body's own immune system, after highly promising early laboratory results.
Researchers from England recently estimated occupational variations in COVID-19 mortality in England and Wales during 2020 and examined how these differences changed post adjustment for non-workplace factors.
Orexigen Therapeutics, Inc. today announced that its 24-week, Phase 2b trial for Empatic(TM) (bupropion SR/zonisamide SR), the Company's second late stage investigational combination drug for the treatment of obesity, met its primary efficacy endpoint by demonstrating statistically significantly greater weight loss for both Empatic doses compared to monotherapies and placebo.
› Verified 1 days ago